Evidence map›Paper›PMID 31703459›Full record

ArticleMolecules (Basel, Switzerland)2019

Chemical Constituents from

Xuelin Shi, Zhongjie Li, Weiwei Cai, Yixiao Liu, Shuangshuang Li, Min Ai, Jiangnan Sun, Bao Hou, Lulu Ni, Liying Qiu

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Molecular basis and mechanism of action ofChinese herbal medicines · 2023
    Review
  2. Two Lignan Glycosides fromPharmaceuticals (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Xuelin ShiSchool of Pharmaceutical Sciences, Jiangnan University, Wuxi 214122, China.ORCID 0000-0002-9652-652X
Zhongjie LiSchool of Pharmaceutical Sciences, Jiangnan University, Wuxi 214122, China.
Weiwei CaiDepartment of Basic Medicine, Wuxi School of Medicine, Jiangnan University, Wuxi 214122, China.
Yixiao LiuDepartment of Basic Medicine, Wuxi School of Medicine, Jiangnan University, Wuxi 214122, China.
Shuangshuang LiDepartment of Basic Medicine, Wuxi School of Medicine, Jiangnan University, Wuxi 214122, China.
Min AiDepartment of Basic Medicine, Wuxi School of Medicine, Jiangnan University, Wuxi 214122, China.
Jiangnan SunDepartment of Basic Medicine, Wuxi School of Medicine, Jiangnan University, Wuxi 214122, China.
Bao HouDepartment of Basic Medicine, Wuxi School of Medicine, Jiangnan University, Wuxi 214122, China.
Lulu NiDepartment of Basic Medicine, Wuxi School of Medicine, Jiangnan University, Wuxi 214122, China.
Liying QiuDepartment of Basic Medicine, Wuxi School of Medicine, Jiangnan University, Wuxi 214122, China.
Jiangnan University · CN

Funding

Fundamental Research Funds for the Central Universities JUSRP11754Jiangsu Natural Science Foundation BK20170179National Natural Science Foundation of China 81700364Postgraduate Research & Practice Innovation Program of Jiangsu Provence SJCX18_0642
6 · The paper itself

Abstract

This study describes the chemical constituents of

Indexed as

AntioxidantsAlbizziaCell ProliferationFatty LiverHep G2 CellsHumansHuman Umbilical Vein Endothelial CellsLignansMass SpectrometryNuclear Magnetic Resonance, BiomolecularOleic AcidOxidation-ReductionPalmitic AcidAntioxidantsLignansOleic AcidPalmitic AcidAlbiziae Cortexanti-oxidationchemical constituentslignanproliferationsteatosis

Identifiers

PMID31703459
PMCPMC6891805
OpenAlexW2988749679

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.